Therapeutic Plasma Exchange Market Report Examines Industry Trends, Growth Drivers And Future Outlook

The therapeutic plasma exchange market is positioned for significant expansion in the coming years, driven by ongoing advancements and growing clinical demand. Understanding the current market size, key players, and emerging trends provides valuable insight into how this sector is evolving and the opportunities it holds through to 2030.

Therapeutic Plasma Exchange Market Size and Growth Outlook
The therapeutic plasma exchange market is projected to reach $2.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.0%. This positive trajectory is propelled by increasing demand for cutting-edge autoimmune treatments, wider adoption of membrane separation technologies, growth in outpatient apheresis services, and heightened investments in blood purification methods. Additionally, the emphasis on tailored immunological therapies is contributing to the market's expanding footprint. Among the notable trends are the rise in automated plasma exchange devices, broader use of therapeutic plasma exchange (TPE) in managing neurological conditions, the shift toward high-efficiency separation technologies, expansion of hospital apheresis units, and a stronger focus on treatment safety and real-time monitoring.

The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.61 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased diagnosis of autoimmune disorders, expansion of hospital transfusion services, availability of centrifugation-based technologies, growing clinician familiarity with apheresis procedures, adoption of standardized treatment protocols.

Download a free sample of the therapeutic plasma exchange market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Players Impacting the Therapeutic Plasma Exchange Industry
Several leading organizations are prominent within the therapeutic plasma exchange landscape, including Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Octapharma AG, Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, and Kawasumi Laboratories America Inc. A notable recent development occurred in October 2025 when Accord Plasma B.V., based in the Netherlands, acquired Prothya Biosolutions Belgium BV. This acquisition strengthens Accord Plasma's global plasma therapy network by incorporating Prothya's expertise in European plasma fractionation, enhancing production capacity, and improving access to critical plasma-derived medicines across several regions. Prothya Biosolutions operates key manufacturing sites and plasma collection centers vital to supplying essential plasma therapies.

Automation and Safety as Drivers of Therapeutic Plasma Exchange Adoption
A growing number of companies in the therapeutic plasma exchange field are prioritizing automation to streamline clinical workflows and enhance patient safety. Automation involves leveraging technology to perform procedures with minimal manual intervention, which improves efficiency and consistency. For example, in November 2024, Terumo BCT, a US-based medical device manufacturer, rolled out software update V12.1 for its Spectra Optia Apheresis System. This update enhances the user interface, boosts cybersecurity measures, and refines workflow features such as automatic pump pauses during single needle exchanges and alarm management. The system supports therapeutic plasma exchange with a high plasma removal efficiency averaging 87%, a low extracorporeal volume of 141 mL, and minimal platelet loss of just 1.0%. These advancements in automation and device safety are accelerating the adoption of TPE in hospitals and specialty clinics worldwide.

View the full therapeutic plasma exchange market report:
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Limitations Affecting Therapeutic Plasma Exchange Market Expansion
Despite technological progress and increased clinical use, challenges remain that restrict broader adoption of therapeutic plasma exchange, especially in resource-limited environments. High initial capital investment for equipment and the necessity for trained healthcare personnel continue to be significant barriers. These factors limit the availability of TPE services in lower-income settings, where access to advanced therapies is often constrained.

Therapeutic Plasma Exchange Market Segmentation
The therapeutic plasma exchange market is categorized across several segments to provide a detailed understanding of its structure:
1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications
3) By Technology: Centrifugation, Membrane Separation
4) By End User: Blood Collection Centers, Hospitals and Clinics, Transfusion Centers, Other End Users

Each category includes subsegments such as:
- Within TPE: Manual TPE and Automated TPE
- Within DFPP: Single-Stage DFPP and Multi-Stage DFPP

This segmentation helps identify the specific areas of demand and technological preferences shaping the market's future development.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.